Incannex Healthcare Ltd ADR (IXHL) Stock Analysis

Incannex Healthcare Ltd ADR (IXHL) is a publicly traded company in the HEALTHCARE sector. It trades at $3.05, carries a market capitalization of $38.53M. This page summarizes the public market data, fundamentals, and frequently asked questions for IXHL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

Incannex Healthcare Ltd ADR currently has a Bearish sentiment score of -0.16.

About Incannex Healthcare Ltd ADR

Incannex Healthcare Ltd ADR is a pioneering entity within the rapidly expanding medicinal cannabinoid sector, dedicated to the research, development, and commercialization of advanced cannabinoid therapies in Australia. Based in Sydney, the company is focused on harnessing the therapeutic potential of cannabinoids to enhance patient outcomes, supported by a robust pipeline of clinical programs. With a commitment to regulatory compliance and innovative research, Incannex is strategically posit...

GNG Research Analysis

GNG Research scores Incannex Healthcare Ltd ADR (IXHL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for IXHL.

Frequently Asked Questions

Does IXHL pay dividends?

Incannex Healthcare Ltd ADR (IXHL) does not currently pay a regular dividend.

What is IXHL's market cap?

Incannex Healthcare Ltd ADR (IXHL) has a market capitalization of $38.53M with a current stock price of $3.05.